JP2019521651A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019521651A5 JP2019521651A5 JP2018558310A JP2018558310A JP2019521651A5 JP 2019521651 A5 JP2019521651 A5 JP 2019521651A5 JP 2018558310 A JP2018558310 A JP 2018558310A JP 2018558310 A JP2018558310 A JP 2018558310A JP 2019521651 A5 JP2019521651 A5 JP 2019521651A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- group
- amino acid
- acid sequence
- sequence selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021166630A JP2022002541A (ja) | 2016-05-02 | 2021-10-11 | 抗Ｋｖ１．３抗体ならびにその産生方法および使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662330420P | 2016-05-02 | 2016-05-02 | |
| US62/330,420 | 2016-05-02 | ||
| US201662416447P | 2016-11-02 | 2016-11-02 | |
| US62/416,447 | 2016-11-02 | ||
| PCT/US2017/030612 WO2017192567A1 (en) | 2016-05-02 | 2017-05-02 | ANTI-Kv1.3 ANTIBODIES, AND METHODS OF PRODUCTION AND USE THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021166630A Division JP2022002541A (ja) | 2016-05-02 | 2021-10-11 | 抗Ｋｖ１．３抗体ならびにその産生方法および使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019521651A JP2019521651A (ja) | 2019-08-08 |
| JP2019521651A5 true JP2019521651A5 (https=) | 2020-06-18 |
| JP7082065B2 JP7082065B2 (ja) | 2022-06-07 |
Family
ID=60203481
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018558310A Expired - Fee Related JP7082065B2 (ja) | 2016-05-02 | 2017-05-02 | 抗Ｋｖ１．３抗体ならびにその産生方法および使用方法 |
| JP2021166630A Withdrawn JP2022002541A (ja) | 2016-05-02 | 2021-10-11 | 抗Ｋｖ１．３抗体ならびにその産生方法および使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021166630A Withdrawn JP2022002541A (ja) | 2016-05-02 | 2021-10-11 | 抗Ｋｖ１．３抗体ならびにその産生方法および使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11597763B2 (https=) |
| EP (1) | EP3452084A4 (https=) |
| JP (2) | JP7082065B2 (https=) |
| CN (1) | CN109862907A (https=) |
| AU (1) | AU2017260232B2 (https=) |
| CA (1) | CA3022961A1 (https=) |
| IL (1) | IL262747A (https=) |
| WO (1) | WO2017192567A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113559075A (zh) | 2014-11-17 | 2021-10-29 | 康泰科思特生物制药公司 | 奥那司酮延长释放组合物和方法 |
| WO2018102369A1 (en) | 2016-11-30 | 2018-06-07 | Arno Therapeutics, Inc. | Methods for onapristone synthesis dehydration and deprotection |
| EP3793614A4 (en) | 2018-04-30 | 2022-04-20 | Integral Molecular, Inc. | GLUCOSE TRANSPORTER-4 ANTIBODIES, PROCESSES FOR THEIR PRODUCTION AND THEIR USES |
| EP3924389A4 (en) | 2019-02-15 | 2023-06-14 | Integral Molecular, Inc. | CLAUDIN-6 ANTIBODIES AND THEIR USES |
| CN113661175A (zh) | 2019-02-15 | 2021-11-16 | 整体分子公司 | 包含共同轻链的抗体及其用途 |
| CA3176090A1 (en) * | 2020-03-30 | 2021-10-07 | Crystal Bioscience Inc. | Anti-gipr antibody and methods of use thereof |
| EP4626933A1 (en) | 2022-11-30 | 2025-10-08 | Integral Molecular, Inc. | Antibodies directed to claudin 6, including bispecific formats thereof |
| CN120865419A (zh) * | 2025-08-02 | 2025-10-31 | 广东工业大学 | 一种用于检测肝癌标志物gpc3的禽源单链抗体、试剂盒、检测方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6861405B2 (en) * | 2001-06-12 | 2005-03-01 | Yale University | Compositions and methods relating to glucose metabolism, weight control, and food intake |
| US7319142B1 (en) * | 2004-08-31 | 2008-01-15 | Monsanto Technology Llc | Nucleotide and amino acid sequences from Xenorhabdus and uses thereof |
| AU2006324847A1 (en) | 2005-12-15 | 2007-06-21 | Genegrafts Ltd. | Polynucleotides and polypeptide of Human KV1.3, compositions comprising same and methods of using same |
| WO2007139771A1 (en) | 2006-05-22 | 2007-12-06 | The Johns Hopkins University | Kv channels in neurodegeneration and neuroprotection |
| WO2010126590A1 (en) | 2009-04-27 | 2010-11-04 | Cold Spring Harbor Laboratory | Ptp1b inhibitors |
| EP2287202A1 (en) | 2009-08-07 | 2011-02-23 | Dublin City University | Anti-sialic acid antibody molecules |
| JP5765814B6 (ja) | 2009-10-21 | 2018-06-27 | 国立大学法人広島大学 | インテグリンα８β１特異的モノクローナル抗体 |
| CN102180950B (zh) | 2011-02-24 | 2013-06-05 | 华中科技大学同济医学院附属协和医院 | 一种人源性电压门控钾通道1.3免疫原性肽段及其用途 |
| WO2014016737A1 (en) | 2012-07-24 | 2014-01-30 | Pfizer Inc. | Novel chicken monoclonal antibodies against human phosphorylated tau and uses thereof |
| RS57422B1 (sr) | 2013-01-25 | 2018-09-28 | Janssen Biotech Inc | Antagonisti kv1.3 i postupci za upotrebu |
| CN103713129B (zh) | 2013-12-18 | 2016-02-10 | 中国医学科学院北京协和医院 | 分子标记物在甲状旁腺肿瘤诊断中的用途 |
| TWI681969B (zh) * | 2014-01-23 | 2020-01-11 | 美商再生元醫藥公司 | 針對ｐｄ-１的人類抗體 |
| NL2013661B1 (en) | 2014-10-21 | 2016-10-05 | Ablynx Nv | KV1.3 Binding immunoglobulins. |
-
2017
- 2017-05-02 WO PCT/US2017/030612 patent/WO2017192567A1/en not_active Ceased
- 2017-05-02 AU AU2017260232A patent/AU2017260232B2/en not_active Ceased
- 2017-05-02 JP JP2018558310A patent/JP7082065B2/ja not_active Expired - Fee Related
- 2017-05-02 CN CN201780041381.XA patent/CN109862907A/zh active Pending
- 2017-05-02 US US16/098,670 patent/US11597763B2/en active Active
- 2017-05-02 CA CA3022961A patent/CA3022961A1/en active Pending
- 2017-05-02 EP EP17793147.4A patent/EP3452084A4/en not_active Withdrawn
-
2018
- 2018-11-04 IL IL262747A patent/IL262747A/en unknown
-
2021
- 2021-10-11 JP JP2021166630A patent/JP2022002541A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019521651A5 (https=) | ||
| An | Therapeutic monoclonal antibodies: from bench to clinic | |
| JP2020508655A5 (https=) | ||
| Perosa et al. | CD20: a target antigen for immunotherapy of autoimmune diseases | |
| AU2015206002B2 (en) | Neutralizing human monoclonal antibodies against Hepatitis B Virus surface antigen | |
| JP2020525032A5 (https=) | ||
| JP2020055849A5 (https=) | ||
| JP2018512138A5 (https=) | ||
| JP2019520063A5 (https=) | ||
| HRP20120701T1 (hr) | Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1 | |
| RU2739955C2 (ru) | Анти-pre-s1 hbv антитела | |
| RU2010130994A (ru) | Агенты против клетки-мишени, нацеленные на cd138, и их применение | |
| US11597763B2 (en) | Anti-Kv1.3 antibodies, and methods of production and use thereof | |
| JP2018526981A5 (https=) | ||
| R. Strohl | Antibody discovery: sourcing of monoclonal antibody variable domains | |
| RU2022108410A (ru) | Терапевтические антитела против лиганда cd40 | |
| JP2018148915A5 (https=) | ||
| JP2018519804A5 (https=) | ||
| JP2018502068A5 (https=) | ||
| IL277899B2 (en) | Methods and preparations for treating yellow fever | |
| US9567390B2 (en) | Humanized high affinity recombinant antibody against Hepatitis B surface antigen | |
| US20230091175A1 (en) | Method for improving affinity of anti-cytokine antibody for antigen, method for producing anti-cytokine antibody, and anti-cytokine antibody | |
| KR20210046725A (ko) | 신규 암 면역요법 항체 조성물 | |
| Kim et al. | Construction of a humanized antibody to hepatitis B surface antigen by specificity-determining residues (SDR)-grafting and de-immunization | |
| Tiwari et al. | Humanization of high affinity anti-HBs antibody by using human consensus sequence and modification of selected minimal positional template and packing residues |